[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
August 31, 1963

Protein-Bound Iodine in Patients Receiving Perphenazine

Author Affiliations

Newtown, Conn.

Clinical Director (Dr. Oltman), and Assistant Superintendent (Dr. Friedman), Fairfield State Hospital.

JAMA. 1963;185(9):726-727. doi:10.1001/jama.1963.03060090058022

IN A RECENT STUDY,1 it was reported that 11 of 32 chronically schizophrenic patients (34%) who had been receiving perphenazine over a "considerable period," had an elevated PBI level, ie, over 8.0 μg/100 cc. These patients did not exhibit any evidence of thyrotoxicosis. It was assumed that perphenazine alters the PBI by some unexplained mechanism.

The current study was pursued both to confirm these previous findings and to elicit further data in this area. Fifty hospitalized, chronically psychotic individuals (29 males and 21 females) who had been receiving perphenazine for at least 6 months were chosen at random. The only other criterion for inclusion in the study was the absence of administration of any other drug. In the group there were 46 schizophrenic patients, 2 chronically manic, and 2 with psychosis due to mental deficiency. They had received perphenazine for periods ranging from 8 to 50 months.

The level

First Page Preview View Large
First page PDF preview
First page PDF preview